Deleterious PALB2 Gene Mutation
2 clinical trials · Condition
◉ Watch Deleterious PALB2 Gene Mutation
| Record | Firm | Date |
|---|---|---|
| Niraparib + Dostarlimab In BRCA Mutated Breast Cancer (NCT04584255) | Dana-Farber Cancer Institute | 2020-12-18 |
| Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations (NCT02760849) | M.D. Anderson Cancer Center | 2016-05-02 |
Track Deleterious PALB2 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.